100 likes | 274 Views
FOLATE: FROM FOOD TO FUNCTIONALITY & OPTIMAL HEALTH (QLK1-1999-00576). Paul Finglas (Scientific Coordinator) Nutrition Health & Consumer Science Division. Institute of Food Research. Folate protects against NTDs Low folate+MTHFR TT » >Hcy Fortification all flours at 240 µg/100g (COMA)?
E N D
FOLATE: FROM FOOD TO FUNCTIONALITY & OPTIMAL HEALTH(QLK1-1999-00576) Paul Finglas (Scientific Coordinator) Nutrition Health & Consumer Science Division Institute of Food Research
Folate protects against NTDs Low folate+MTHFR TT » >Hcy Fortification all flours at 240µg/100g (COMA)? Lowers Hcy – may be risk factor for CVD & stroke Polymorphisms in MTHFR may protect against some cancers but have an opposite effect in others Current requirements based on absence of deficiency - not risk of NTD or genotype effects Background
Total cost = 2.9 meuro [EU: 2.2 (76%)] 42 months, 1/2/00-31/7/03 13 partners from 9 EU countries Research institutes, universities, clinical & industry Links to researchers in USA, Australia & SA Web site: www.ifr.bbsrc.ac.uk/folate Project Details
Development of foods + improved use of raw materials & processing techniques for diet rich in folates Quantification of bioavailability of natural folate versus PGA from fortified foods Efficacy of folates in moderating specific risk factors for disease Pre-competitive information for development of sustainable dietary folate strategies for use within European food industry Project Aims
Preparation of RELATIONSHIPS BETWEEN WORKPACKAGES model foods and isolates Process effects (WPs 2 & 2.2; P1) (WP 3; P5) Folate content / Intrinsic labelling forms of foods Labelled isolates Effects of INTAKE processing (WPs 1 & 1.2; P6) In Vitro mode Review data for (WP 4; P8) baseline intakes Standardised Dietary components methods for food Age Optimise processing & Genotype folates BIOAVAILABILITY REQUIREMENTS Effects (WPs 7.1 & 7.2) Effect of age on uptake & retention (P2) WHOLE BODY In Vivo model Effect of genotype & form on FOLATE absorbility (P10) (WPs 5.1 & 5.2) STATUS & Increased fortification on B 12 Ileostomy (P5) METABOLISM deficiency - dafe intakes Stable isotopes (P1) Information on fortification / supplementation strategies Bioactivity & Functionality (WPs 6.1 & 6.2; P1) Standardised methods for blood folate analysis Homocysteine lowering Isotopic urinary excretion
Fermentation effects on folate content/forms in vegetables, dairy foods & cereals (SW) Rye bread - sour dough processing conditions & rye varieties (FI) Effects of high pressure vs mild pasteurisation processing on folates in oranges & juices (IT) Effects of minimal processing vs autoclaving on folates in vegetables (tomatoes & peas) (ES) Process Effects (WP3)
Rome Study: Phase A Placebo 56 Upper 25th Natural diet (0.2mg/d) 56 1200 300 56 5-MeTHF (0.2mg/d) 56 Folic acid (0.2mg/d) 1200 subjects enrolled out of 2000 informed Upper 25th percentile selected = 300 subjects
Accuracy/reliability of current food folate data - implications for intake calculations New/refined processing techniques for foods with enhanced folate content, bioavailability & functionality Rapid in vitro models for predicting folate availability for absorption & dietary factors that influence this In vivo models for predicting folate absorption + factors that influence rate/limit of absorption Efficacy of various folate strategies for lowering plasma Hcy in general population (influence of age, sex & genotype) Major Project Deliverables
Web Site (www.ifr.bbsrc.ac.uk/folate) Newsletter (2/year) Project Meetings (2/year) & summary reports Talks and posters at relevant conferences: Bioavailability 2001 (Interlaken) Homocysteine Conference (Sorrento) ICN (Vienna) Final Conference (2003?) Project Dissemination